Drawing for NEORESIST

USPTO serial 79211993

NEORESIST

Reviewed by CopyMark Law Group

Reg. 5420630Status 709
Filing date
Status date
Registration date
Mar 13, 2018
Examiner
KENEALY, NATALIE LANGFORD
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NEORESIST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karla M. Weyand

511 Benedict Ave.IP Dept.Tarrytown, NY 10591

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratories, namely, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, namely, for the detection, analysis and treatment of cancer; cultures of microorganisms for medical and veterinary useSECTION 71 - CANCELLED—
042Scientific and technological services, namely, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer softwareSECTION 71 - CANCELLED—
044Medical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseasesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 3, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 2, 2025INPCINVALIDATION PROCESSED—
May 27, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 27, 2024C71TCANCELLED SECTION 71—
Mar 13, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 24, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 14, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 15, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 15, 2018FIMPFINAL DISPOSITION PROCESSED—
Jun 13, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 13, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 26, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 26, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 22, 2017GPNXNOTIFICATION PROCESSED BY IB—
Dec 6, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 6, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 17, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 6, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 1, 2017ALIEASSIGNED TO LIE—
Oct 23, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 11, 2017RFNTREFUSAL PROCESSED BY IB—
Jul 27, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 27, 2017RFRRREFUSAL PROCESSED BY MPU—
Jul 22, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 21, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 14, 2017DOCKASSIGNED TO EXAMINER—
Jul 14, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 13, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance